• Request a free trial Log in
  • Products
  • Solutions
  • Data
  • News & Analysis
  • About
  • Blog
Log in Request a free trial

News & Analysis

driven by the PitchBook Platform
Articles
Research Center
All articles
All
  • Venture capital
  • Private equity
  • M&A
  • Tech
  • Europe
  • Leveraged loans
Research Center Subscribe

Market Map: Information security guards against economic threats

February 3, 2023

Slump puts startups' fates in hands of all-powerful VC insiders

February 3, 2023

Morgan Stanley's $2.5B fund keeps secondaries momentum rolling

February 2, 2023

Capsule startup's €40M round fuels European space ambition

February 1, 2023

Is Vista's $4.6B KnowBe4 deal a swan song for big take-privates?

February 1, 2023

Greybull eyes distress deal for battery-maker Britishvolt

February 1, 2023

Why VC valuations look too high to limited partners

January 31, 2023

Inflexion exits Scott Dunn as Europe's travel industry pursues pandemic recovery

January 31, 2023

Healthcare Services Report

featured report

Q4 2022

Healthcare Services Report

February 3, 2023

The Q4 2022 Healthcare Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.

Join the more than 1.5 million industry professionals who get our daily newsletter!

After Microsoft’s OpenAI play, a feast at the generative AI buffet
AI

After Microsoft’s OpenAI play, a feast at the generative AI buffet

January 30, 2023

Two generative AI startups—Character and Anthropic—are seeking hundreds of millions of dollars at unicorn valuations as investors scramble to secure stakes in the segment.

Spain breaks its record for PE deal count in 2022
Europe

Spain breaks its record for PE deal count in 2022

January 30, 2023

In 2022, Spain's private equity industry saw a record number of deals completed, despite the total capital invested in the country dropping.

Latest headlines

  • VC, PE losses persist in new data, but other strategies show resilience
  • Tiger Global reduces target to $5B
  • Tykhe Block Ventures launches $30M blockchain fund
  • Just Climate backs decarbonization specialists
  • Patient Square closes first PE fund on $3.9B
  • Ariel Alternatives raises $1.45B
  • Global VC deals for February 2, 2023
  • Global PE deals for February 2, 2023
  • Tin Alley Ventures wraps up $71M
  • Global VC deals for February 1, 2023
  • Ardian to open office in Abu Dhabi
  • Tesco moves to buy Paperchase
  • North Hudson launches $275M oil and gas credit fund
  • KKR sets aside $250M for testing platform
  • Shein to name former SoftBank exec head of LatAm
  • Global PE deals for February 1, 2023
  • US DFC to support Ukrainian companies
  • Embedded Ventures kicks off first fund
  • Brookfield, DWS swap PE business
  • Global VC deals for January 31, 2023
  • UK-listed SPAC eyes Istesso merger
  • Marqeta to buy Power Finance for $223M
  • Fidelity cuts Twitter valuation—again
  • Renault, Nissan announce changes to partnership
  • Theta Capital launches third blockchain VC fund

Most read articles

  • Even startups with lots of runway probably can't grow into those sky-high valuations
  • Private-debt market braces for stormy seas
  • Why VC valuations look too high to limited partners
  • Lightspeed's new head of gaming wants to rethink investments in the vertical
  • Unicorn companies tracker

Most read research

  • 2022 Annual Global M&A Report
  • Q1 2023 PitchBook Analyst Note: When Dry Powder Stays Dry
  • Q1 2023 PitchBook Analyst Note: The Role of Placement Agents in GP Fundraising
  • 2022 Annual US PE Breakdown
  • Q1 2023 PitchBook Analyst Note: Takeaways From the 2023 J.P. Morgan Healthcare Conference: Deals, Trends, and Predictions
Arch Ventures-incubated clinical trials startup leaves stealth with $203M
Healthtech

Arch Ventures-incubated clinical trials startup leaves stealth with $203M

January 27, 2023

Paradigm, a healthtech startup that has received a $203 million Series A, is creating technology to match patient records with clinical trial criteria.

3 ways institutional portfolios could find balance this year
Weekend Analysis

3 ways institutional portfolios could find balance this year

January 27, 2023

Some investors are turning to the secondaries market to steady institutional portfolios through LP-led transactions.

CVCs take part in more than a fifth of European VC deals
Corporate VC

CVCs take part in more than a fifth of European VC deals

January 27, 2023

More than 1 in 5 European venture deals involved corporate venture capital in 2022—a new record for CVC participation.

On the podcast: Leveraged loan warning signs
Podcast

On the podcast: Leveraged loan warning signs

January 27, 2023

In the first episode of Season 7, we look at the clouds gathering in the US and European leveraged loan markets.

PE-backed Ionos eyes €3.15B public valuation after Euro IPO drought
Private Equity

PE-backed Ionos eyes €3.15B public valuation after Euro IPO drought

January 27, 2023

The German web hosting company could be Europe's largest IPO this year as it seeks a €3.15B valuation.

Article
Tweets by PitchBook
Products
  • PitchBook Desktop
  • PitchBook Mobile
  • CRM Integration
  • Excel Plugin
  • Chrome Extension
  • Direct Data
  • Institutional Research Group
  • Morningstar Institutional Equity Research
  • Product Releases

PitchBook for

  • Private Market Valuations
  • Venture Capital
  • Private Equity
  • Hedge Funds
  • Startups
Profile Previews
Solutions
  • Private Market Intel
  • Fundraising
  • Deal Sourcing
  • Due Diligence
  • Business Development
  • Networking
  • Deal Execution
  • Benchmarking
  • Asset Allocation
Blog Webinars Video Library
Data
  • Companies
  • Investors
  • Deals
  • M&A
  • Limited Partners
  • Funds
  • Financials
  • Advisors
  • Professionals
  • Debt
  • Lenders
  • Data Operations
Leveraged Commentary and Data
News & analysis
  • Reports
  • Newsletter
  • Advertise
  • Research & Analysis Team
About
  • Customer Success
  • Client Testimonials
  • What Sets Us Apart
  • Press Inquiries
  • Partnerships
  • Careers

Follow us

  • 
  • 
  • 
  • 
  • 

US Headquarters

  • +1 (206) 623.1986
  • 901 Fifth Avenue
  • Suite 1200
  • Seattle, WA 98164

European Headquarters

  • +44 (0) 20 8037.2308
  • 1st Floor Saffron House
  • 6-10 Kirby Street
  • London EC1N 8TS
  • United Kingdom

Asia-Pacific Headquarters

  • Unit 6807-09, The Center
  • 99 Queen’s Road Central
  • Hong Kong
Contact Us
  • info@pitchbook.com
  • Request Research
  • Profile Request
  • Deal Submission

Follow us

  • 
  • 
  • 
  • 
  • 

© 2023 PitchBook. Win what’s next. All rights reserved.

  • Terms of Use
  • Privacy Policy
  • California Consumer: Do Not Sell My Info